Method for producing dumbbell-shaped DNA vectors
A PCR-based, cloning-free method synthesizes dumbbell-shaped DNA vectors efficiently and cost-effectively, addressing production costs and safety risks associated with existing methods, enhancing cellular delivery and reducing transgene silencing.
JP7751885B2Active Publication Date: 2025-10-09NATIONAL UNIVERSITY OF SINGAPORE
Patent Information
- Application Number
- JP2022511226
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2019-08-22
- Filing Date
- 2020-08-21
- Publication Date
- 2025-10-09
- Estimated Expiration
- 2040-08-21
Smart Images

Figure 0007751885000004 
Figure 0007751885000005 
Figure 0007751885000006
Abstract
A dumbbell-shaped DNA minimal vector is a gene vector consisting only of a gene expression cassette of interest and a closed-end loop structure. Dumbbell vectors for expressing small hairpin RNAs or microRNAs have an extremely small size, which is advantageous for cellular delivery and nuclear spread. Conventional strategies for creating small RNA-expressing dumbbell vectors require cloning of each plasmid vector, which is then used for dumbbell protection. Herein, the inventors present a novel cloning-free method for creating small RNA-expressing dumbbell vectors, which also does not require any restriction endonucleases. The method involves PCR amplification of a universal DNA template using primers containing the sense or antisense strand of the target sequence, denaturing and refolding the amplified product to form a stem-loop structure, and covalently closing the structure using DNA ligase to obtain a dumbbell structure.
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Method and device for gene sequencing of plurality of mixed DNA (Deoxyribonucleic Acid) or RNA (Ribonucleic Acid) sequences
CN103045726A
Multiplex PCR method
CN110144387A
Efficient Process For Producing Dumbbell Dna
US20080153763A1
Compositions and methods comprising control nucleic acid
WO2003016550A2
Use of a DNA expression construct
WO2012032114A1